ATE466013T1 - Pyrroloä3,2-cüpyridinderivate und verfahren zu deren herstellung - Google Patents

Pyrroloä3,2-cüpyridinderivate und verfahren zu deren herstellung

Info

Publication number
ATE466013T1
ATE466013T1 AT05808482T AT05808482T ATE466013T1 AT E466013 T1 ATE466013 T1 AT E466013T1 AT 05808482 T AT05808482 T AT 05808482T AT 05808482 T AT05808482 T AT 05808482T AT E466013 T1 ATE466013 T1 AT E466013T1
Authority
AT
Austria
Prior art keywords
derivatives
pyrroloä3
cüpyridine
production
pharmaceutically acceptable
Prior art date
Application number
AT05808482T
Other languages
English (en)
Inventor
Jae-Gyu Kim
Byung-Nak Ahn
Hyouk-Woo Lee
Suk-Won Yoon
Young-Ae Yoon
Hyun-Ho Choi
Heui-Il Kang
Original Assignee
Yuhan Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yuhan Corp filed Critical Yuhan Corp
Application granted granted Critical
Publication of ATE466013T1 publication Critical patent/ATE466013T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
AT05808482T 2004-09-03 2005-09-03 Pyrroloä3,2-cüpyridinderivate und verfahren zu deren herstellung ATE466013T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20040070534 2004-09-03
PCT/KR2005/002925 WO2006025715A1 (en) 2004-09-03 2005-09-03 Pyrrolo[3,2-c]pyridine derivatives and processes for the preparation thereof

Publications (1)

Publication Number Publication Date
ATE466013T1 true ATE466013T1 (de) 2010-05-15

Family

ID=36000317

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05808482T ATE466013T1 (de) 2004-09-03 2005-09-03 Pyrroloä3,2-cüpyridinderivate und verfahren zu deren herstellung

Country Status (16)

Country Link
US (1) US7541366B2 (de)
EP (1) EP1805177B9 (de)
JP (1) JP4989477B2 (de)
KR (1) KR100946220B1 (de)
CN (1) CN100564379C (de)
AT (1) ATE466013T1 (de)
AU (1) AU2005280739B2 (de)
BR (1) BRPI0514907A (de)
CA (1) CA2579083C (de)
DE (1) DE602005020957D1 (de)
DK (1) DK1805177T3 (de)
ES (1) ES2342478T3 (de)
HK (1) HK1105978A1 (de)
MX (1) MX2007002076A (de)
RU (1) RU2375359C2 (de)
WO (1) WO2006025715A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011004882A1 (ja) 2009-07-09 2011-01-13 ラクオリア創薬株式会社 消化管運動異常が関与する疾患を治療するためのアシッドポンプ拮抗剤
CA3217238A1 (en) * 2015-07-20 2017-01-26 Genzyme Corporation Colony stimulating factor-1 receptor (csf-1r) inhibitors
KR20220129554A (ko) * 2019-12-17 2022-09-23 더 락커펠러 유니버시티 Enl/af9 yeats의 억제제
JP2024500919A (ja) 2020-12-23 2024-01-10 ジェンザイム・コーポレーション 重水素化コロニー刺激因子－１受容体（ｃｓｆ－１ｒ）阻害剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3269604D1 (en) * 1981-06-26 1986-04-10 Schering Corp Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
JP3465827B2 (ja) * 1993-02-24 2003-11-10 株式会社日清製粉グループ本社 アザインドール誘導体およびこれを有効成分とする抗潰瘍薬
NZ278675A (en) * 1994-01-19 1997-07-27 Sankyo Co Pyrrolopyridazine derivatives; medicaments
SE9704404D0 (sv) * 1997-11-28 1997-11-28 Astra Ab New compounds
US20040110785A1 (en) * 2001-02-02 2004-06-10 Tao Wang Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
FR2822463B1 (fr) * 2001-03-21 2004-07-30 Lipha Derives bicycliques de guanidines et leurs applications en therapeutique
US7361671B2 (en) * 2001-11-15 2008-04-22 The Institute For Pharmaceutical Discovery, Inc. Substituted heteroarylalkanoic acids
TW200301251A (en) * 2001-12-20 2003-07-01 Wyeth Corp Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands

Also Published As

Publication number Publication date
CA2579083A1 (en) 2006-03-09
AU2005280739A1 (en) 2006-03-09
KR100946220B1 (ko) 2010-03-08
EP1805177B9 (de) 2010-09-15
BRPI0514907A (pt) 2008-06-24
US20070249658A1 (en) 2007-10-25
JP4989477B2 (ja) 2012-08-01
EP1805177A4 (de) 2009-07-29
AU2005280739B2 (en) 2010-11-11
DE602005020957D1 (de) 2010-06-10
DK1805177T3 (da) 2010-08-02
JP2008511619A (ja) 2008-04-17
MX2007002076A (es) 2007-03-29
KR20060051003A (ko) 2006-05-19
EP1805177A1 (de) 2007-07-11
RU2375359C2 (ru) 2009-12-10
HK1105978A1 (en) 2008-02-29
CA2579083C (en) 2011-06-14
EP1805177B1 (de) 2010-04-28
US7541366B2 (en) 2009-06-02
ES2342478T3 (es) 2010-07-07
WO2006025715A1 (en) 2006-03-09
CN100564379C (zh) 2009-12-02
CN101010322A (zh) 2007-08-01
RU2007112111A (ru) 2008-10-10

Similar Documents

Publication Publication Date Title
ATE533765T1 (de) Pyrroloä2,3-cüpyridinderivate und verfahren für deren herstellung
ATE518858T1 (de) Pyrroloä3,2-cüpyridinderivate und herstellungsverfahren dafür
NO20063231L (no) Pyrido[2,3-D]pyrimidin-2,4-diaminer som PDE 2 inhibitorer
DE602004007239D1 (de) 4-AMINOTHIENOÄ2,3-dÜ PYRIMIDIN -6-CARBONITRIL-DERIVATIVE ZUR VERWENDUNG ALS PDE7 INHIBITOREN
WO2006010546A3 (en) Aryl-pyridine derivatives as 11-beta-hsd1 inhibitors
MEP23808A (en) Pyridine[3,4-b]pyrazinones
WO2006126082A3 (en) Pyridine [3,4-b] pyrazinones as pde-5 inhibitors
WO2005051906A3 (en) Heterocyclic inhibitors of mek and methods of use thereof
WO2007120647A3 (en) Compositions useful as inhibitors of voltage-gated sodium channels
NO20070445L (no) Pyrimidinderivater.
WO2005042497A3 (en) Benzimidazoles useful as modulators of ion channels
WO2006116733A3 (en) Protein kinase inhibitors
WO2006065590A3 (en) Pyridine and pyrimidine antiviral compositions
NO20073551L (no) Nikotinacetylkolinreseptorligander
AP1564A (en) Piperazinyl sulfonic acid derivatives, their pharmaceutical compositions and methods of use.
WO2006072000A3 (en) Xanthurenic acid derivative pharmaceutical compositoins and methods related thereto
WO2006124865A3 (en) Biaryls derivatives useful as modulators of ion channels
ATE466013T1 (de) Pyrroloä3,2-cüpyridinderivate und verfahren zu deren herstellung
WO2005097755A3 (de) Imidazolderivate als hemmer von tyrosinkinase
WO2006004903A3 (en) 1,2-bis-(substituted-phenyl)-2-propen-1-ones and pharmaceutical compositions thereof
NO20073547L (no) Nikotinacetykolinreseptorligander
IS8034A (is) Imídasó[4,5-B]kínólínafleiður og notkun þeirra sem NO-myndunarhemla
ECSP077307A (es) Derivados piridínicos de indolin-2-ona, su preparación y su aplicación en terapéutica
WO2004108094A3 (en) Sulfonamide-substituted chalcone derivatives and their use to treat diseases
WO2007006922A8 (fr) Nouveaux derives 1h-indole-pyridinecarboxamides et 1h-indole-piperidinecarboxamide et leur utilisation comme inducteurs de tyrosine hydroxylase

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties